J Korean Assoc Oral Maxillofac Surg.  2016 Apr;42(2):65-66. 10.5125/jkaoms.2016.42.2.65.

Necessity of standardized protocol for platelet-rich plasma therapy in temporomandibular joint osteoarthritis

• Kim SG

• KMID: 2351727
• DOI: http://doi.org/10.5125/jkaoms.2016.42.2.65

Abstract

No abstract available.

MeSH Terms

Osteoarthritis*
Platelet-Rich Plasma*
Temporomandibular Joint*

Reference

1. Machon V, Hirjak D, Lukas J. Therapy of the osteoarthritis of the temporomandibular joint. J Craniomaxillofac Surg. 2011; 39:127–130. PMID: 20692843.

2. Vernal R, Velásquez E, Gamonal J, Garcia-Sanz JA, Silva A, Sanz M. Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint. Arch Oral Biol. 2008; 53:910–915. PMID: 18508030.

3. Kim JS, Ellman MB, An HS, Yan D, van Wijnen AJ, Murphy G, et al. Lactoferricin mediates anabolic and anti-catabolic effects in the intervertebral disc. J Cell Physiol. 2012; 227:1512–1520. PMID: 21678402.

4. Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014; 95:562–575. PMID: 24291594.

5. Kütük N, Baş B, Soylu E, Gönen ZB, Yilmaz C, Balcioğlu E, et al. Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint. J Oral Maxillofac Surg. 2014; 72:277–284. PMID: 24239096.

6. Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. J Oral Maxillofac Surg. 2015; 73:1706–1713. PMID: 25882438.

7. Bottegoni C, Dei Giudici L, Salvemini S, Chiurazzi E, Bencivenga R, Gigante A. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study. Ther Adv Musculoskelet Dis. 2016; 8:35–41. PMID: 27047571.